Clinical trial

R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer

NCT00544596

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-09-01

PhasePHASE1

Study timeline

Study start (unknown)2007-09-01Date precision: month

Registry last updated2014-04-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Extensive Stage Small Cell Lung Cancerunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

R-(-)-gossypol acetic acidDRUG

cisplatinDRUG · verified · RxNorm: cisplatin

etoposideDRUG · verified · RxNorm: etoposide

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

MadisonWisconsin, United States2 Sioux FallsSouth Dakota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00544596 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.